These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7662244)

  • 1. Prevalence of white coat effect in treated hypertensive patients in the community.
    Myers MG; Oh PI; Reeves RA; Joyner CD
    Am J Hypertens; 1995 Jun; 8(6):591-7. PubMed ID: 7662244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for the white coat effect in general practice patients with suspected and treated hypertension.
    Lindbaek M; Sandvik E; Liodden K; Mjell J; Ravnsborg-Gjertsen K
    Br J Gen Pract; 2003 Oct; 53(495):790-3. PubMed ID: 14601355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White coat effect in treated hypertensive patients: sex differences.
    Myers MG; Reeves RA
    J Hum Hypertens; 1995 Sep; 9(9):729-33. PubMed ID: 8551486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of physician vs automated blood pressure readings on office-induced hypertension.
    Myers MG; Meglis G; Polemidiotis G
    J Hum Hypertens; 1997 Aug; 11(8):491-3. PubMed ID: 9322829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the white-coat effect among hypertensive patients presumed to be at goal.
    Bookstaver DA; Hatzigeorgiou C
    Ann Pharmacother; 2011 Jul; 45(7-8):910-5. PubMed ID: 21750311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of the white-coat effect in hypertensive subjects.
    Mansoor GA; McCabe EJ; White WB
    J Hum Hypertens; 1996 Feb; 10(2):87-92. PubMed ID: 8867561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and predictors of white-coat response in patients with treated hypertension.
    MacDonald MB; Laing GP; Wilson MP; Wilson TW
    CMAJ; 1999 Aug; 161(3):265-9. PubMed ID: 10463047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial.
    Staessen JA; Den Hond E; Celis H; Fagard R; Keary L; Vandenhoven G; O'Brien ET;
    JAMA; 2004 Feb; 291(8):955-64. PubMed ID: 14982911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of white coat hypertension: an ambulatory blood pressure monitoring study.
    Manning G; Rushton L; Millar-Craig MW
    J Hum Hypertens; 1999 Dec; 13(12):817-22. PubMed ID: 10618670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac and vascular morphology in patients with "white-coat hypertension": echocardiographic and ultrasonographic study].
    Cuspidi C; Marabini M; Lonati L; Sampieri L; Pontiggia G; Pelizzoli S; Leonetti G
    G Ital Cardiol; 1995 Dec; 25(12):1581-7. PubMed ID: 8707006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the automated BpTRU measurement device in the assessment of white-coat hypertension and white-coat effect.
    Culleton BF; McKay DW; Campbell NR
    Blood Press Monit; 2006 Feb; 11(1):37-42. PubMed ID: 16410740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical significance of a greater ambulatory versus office blood pressure ('reversed white coat' condition) in a general population.
    Bombelli M; Sega R; Facchetti R; Corrao G; Polo Friz H; Vertemati AM; Sanvito R; Banfi E; Carugo S; Primitz L; Mancia G
    J Hypertens; 2005 Mar; 23(3):513-20. PubMed ID: 15716691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White-coat effect in normotension and hypertension.
    Zakopoulos NA; Kotsis VT; Pitiriga VCh; Toumanidis ST; Lekakis JP; Nanas SN; Vemmos KN; Stamatelopoulos SF; Moulopoulos SD
    Blood Press Monit; 2002 Oct; 7(5):271-6. PubMed ID: 12409886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
    Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
    Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between body-mass index and white-coat hypertension among referred patients.
    Ben-Dov IZ; Mekler J; Ben-Arie L; Bursztyn M
    Blood Press Monit; 2007 Apr; 12(2):95-9. PubMed ID: 17353652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of an automated blood pressure recording device, the BpTRU, to reduce the "white coat effect" in routine practice.
    Myers MG; Valdivieso MA
    Am J Hypertens; 2003 Jun; 16(6):494-7. PubMed ID: 12799100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-four hour ambulatory blood pressure monitoring in general practice.
    Rugnath T; Pillay BJ; Cassimjee MH
    S Afr Med J; 2000 Sep; 90(9):898-904. PubMed ID: 11081143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of automated office blood pressure measurement to reduce the white coat response.
    Myers MG; Valdivieso M; Kiss A
    J Hypertens; 2009 Feb; 27(2):280-6. PubMed ID: 19155785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.